Interleukin-17: friend or foe in atherosclerosis?

S Taleb, A Tedgui, Z Mallat - Current opinion in lipidology, 2010 - journals.lww.com
S Taleb, A Tedgui, Z Mallat
Current opinion in lipidology, 2010•journals.lww.com
Interleukin-17: friend or foe in atherosclerosis? : Current Opinion in Lipidology Interleukin-17:
friend or foe in atherosclerosis? : Current Opinion in Lipidology Log in or Register Subscribe
to journalSubscribe Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced
Search Toggle navigation Subscribe Register Login Articles & Issues For Authors Journal Info
Advanced Search October 2010 - Volume 21 - Issue 5 Previous Article Next Article
Atherosclerosis: cell biology and lipoproteins: Edited by Petri T. Kovanen and Jan Nilsson …
Summary
IL-17 seems to have a modulatory role in atherosclerosis. Future studies are needed to better determine the molecular mechanisms involved in this regulation and examine whether targeting IL-17 pathway will be useful to treat cardiovascular diseases.
Lippincott Williams & Wilkins
Show moreShow less
Save Cite Cited by 87 Related articles All 7 versions